| abstract |
The present invention relates to a polypeptide comprising a mutant fragment of cell surface protein A (OspA), a nucleic acid encoding the same, the polypeptide and / or a nucleic acid (particularly used as a medicament in a method for treating or preventing Borrelia infection) To a pharmaceutical composition, a method of treating or preventing a Borrelia infection, and a method of immunizing a subject. |